Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EntreMed reports positive preclinical results using Endostatin

Dec. 3, 1997

ALVAC-IL-12 gene therapy effective in murine model of breast cancer

Dec. 2, 1997

Heterocyclic antitumor agents from Dainippon

Dec. 2, 1997

Steroidal anticancer compounds isolated from C. africana

Dec. 2, 1997

Angiostatin production mechanism elucidated; may permit large-scale studies

Dec. 2, 1997

U.S. patent covers new melanoma antigen/MAb discovered by Cytoclonal

Dec. 1, 1997

Phase I/II clinical trial of gene therapy for melanoma

Dec. 1, 1997

IL-2 gene therapy for metastatic solid tumors: phase I results

Dec. 1, 1997

BE-32030B: new antitumor agent produced by Nocardia

Dec. 1, 1997

Antileukemic effects described for vesnarinone

Nov. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...